BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34973277)

  • 1. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
    Harrabi SB; von Nettelbladt B; Gudden C; Adeberg S; Seidensaal K; Bauer J; Bahn E; Mairani A; Alber M; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Feb; 167():211-218. PubMed ID: 34973277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients.
    Eulitz J; G C Troost E; Klünder L; Raschke F; Hahn C; Schulz E; Seidlitz A; Thiem J; Karpowitz C; Hahlbohm P; Grey A; Engellandt K; Löck S; Krause M; Lühr A
    Radiother Oncol; 2023 Jan; 178():109422. PubMed ID: 36435337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can scanned proton beam treatment planning for low-grade glioma cope with increased distal RBE and locally increased radiosensitivity for late MR-detected brain lesions?
    Bauer J; Bahn E; Harrabi S; Herfarth K; Debus J; Alber M
    Med Phys; 2021 Apr; 48(4):1497-1507. PubMed ID: 33506555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.
    Eichkorn T; Bauer J; Bahn E; Lischalk JW; Meixner E; Sandrini E; Regnery S; Held T; Hörner-Rieber J; Alber M; Herfarth K; Debus J; König L; Harrabi S
    Radiother Oncol; 2022 Jul; 172():54-64. PubMed ID: 35568281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Contrast Enhancing Brain Lesions in Proton-Treated Patients With Low-Grade Glioma: Clinical Evidence for Increased Periventricular Sensitivity and Variable RBE.
    Bahn E; Bauer J; Harrabi S; Herfarth K; Debus J; Alber M
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):571-578. PubMed ID: 32234554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.
    Tabrizi S; Yeap BY; Sherman JC; Nachtigall LB; Colvin MK; Dworkin M; Fullerton BC; Daartz J; Royce TJ; Oh KS; Batchelor TT; Curry WT; Loeffler JS; Shih HA
    Radiother Oncol; 2019 Aug; 137():95-101. PubMed ID: 31082632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
    Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.
    Kamran SC; Dworkin M; Niemierko A; Bussiere M; Oh KS; Loeffler JS; Shih HA
    Pract Radiat Oncol; 2019; 9(4):e356-e361. PubMed ID: 30790717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.
    Haas-Kogan D; Indelicato D; Paganetti H; Esiashvili N; Mahajan A; Yock T; Flampouri S; MacDonald S; Fouladi M; Stephen K; Kalapurakal J; Terezakis S; Kooy H; Grosshans D; Makrigiorgos M; Mishra K; Poussaint TY; Cohen K; Fitzgerald T; Gondi V; Liu A; Michalski J; Mirkovic D; Mohan R; Perkins S; Wong K; Vikram B; Buchsbaum J; Kun L
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):152-168. PubMed ID: 29619963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
    Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
    Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
    Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
    Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
    Eichkorn T; Lischalk JW; Hörner-Rieber J; Deng M; Meixner E; Krämer A; Hoegen P; Sandrini E; Regnery S; Held T; Harrabi S; Jungk C; Herfarth K; Debus J; König L
    J Neurooncol; 2023 May; 162(3):489-501. PubMed ID: 36598613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.
    Harrabi SB; Bougatf N; Mohr A; Haberer T; Herfarth K; Combs SE; Debus J; Adeberg S
    Strahlenther Onkol; 2016 Nov; 192(11):759-769. PubMed ID: 27363701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential proton boost after standard chemoradiation for high-grade glioma.
    Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
    Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.
    Fuss M; Hug EB; Schaefer RA; Nevinny-Stickel M; Miller DW; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1117-26. PubMed ID: 10613303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.